idUS - Browsing by Author "Molina, José"

Now showing items 1-4 of 4

Article

Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes

Morales Barroso, Isabel; López Cerero, Lorena; Molina, José; Bellido, Mar; Navarro, María Dolores; Serrano, Lara; González-Galán, Verónica; Praena, Julia; Pascual Hernández, Álvaro; Rodríguez-Baño, Jesús (Elsevier, 2017)

The epidemiology and outcomes of bloodstream infections (BSIs) caused by Escherichia coli ST131 isolates not producing ...
Article

Clinical Features of Infections and Colonization by Acinetobacter Genospecies 3

Molina, José; Cisneros, José Miguel; Fernández-Cuenca, Felipe; Rodríguez-Baño, Jesús; Ribera, Anna; Beceiro Casas, Alejandro; Martínez-Martínez, Luis; Pascual Hernández, Álvaro; Bou, Germán; Vila, Jordi; Pachón Díaz, Jerónimo (American Society for Microbiology, 2010-12)

Two hundred twenty-one isolates of Acinetobacter baumannii and 15 of Acinetobacter genospecies 3 (AG3) were consecutively ...
Article

Duration of antibiotic treatment for Gram-negative bacteremia – Systematic review and individual participant data (IPD) meta-analysis

Turjeman, Adi; von Dach, Elodie; Molina, José; Franceschini, Erica; Koppel, Fidi; Yelin, Dana; Rodríguez-Baño, Jesús; Cisneros, José Miguel; Yahav, Dafna (2023)

Background We aim to compare the effect of short versus long treatment duration in Gram-negative bacteremia on all-cause ...
Article

Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial)

Molina, José; Rosso-Fernández, Clara María; Montero-Mateos, Enrique; Paño-Pardo, José Ramón; Solla, María; Guisado Gil, Ana Belén; Lepe Jiménez, José Antonio; Cisneros, José Miguel (2022-12-22)

Background Research priorities in Antimicrobial Stewardship (AMS) have rapidly evolved in the last decade. The need for ...

Browsing by Author "Molina, José"

Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes ﻿

Clinical Features of Infections and Colonization by Acinetobacter Genospecies 3 ﻿

Duration of antibiotic treatment for Gram-negative bacteremia – Systematic review and individual participant data (IPD) meta-analysis ﻿

Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial) ﻿

Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes

Clinical Features of Infections and Colonization by Acinetobacter Genospecies 3

Duration of antibiotic treatment for Gram-negative bacteremia – Systematic review and individual participant data (IPD) meta-analysis

Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial)